- Investing Ideas
- /
- South Korean Pharmaceuticals & Biotech Big Green Snowflakes
South Korean Pharmaceuticals & Biotech Big Green Snowflakes
Results
258
Every company on Simply Wall St ordered by total Snowflake score (not a Buy recommendation).
258 companies
DAE HWA Pharmaceutical
Market Cap: ₩275.4b
A pharmaceutical company, produces and supplies pharmaceutical products in South Korea.
A067080
₩15,720.00
7D
46.0%
1Y
32.3%
MEDIZEN HUMANCARE
Market Cap: ₩6.2b
A research company, engages in the genomic analysis to predict diseases on an individual basis in Asia, the Americas, Europe, and internationally.
A236340
₩2,695.00
7D
3.7%
1Y
-36.0%
AItheNutrigene
Market Cap: ₩3.0b
Provides test-detection solutions for early detection and and prevention of diseases.
A311960
₩989.00
7D
11.2%
1Y
-92.8%
DT&CRO
Market Cap: ₩79.7b
Operates as a full-service CRO provider in South Korea.
A383930
₩6,260.00
7D
-15.4%
1Y
-48.9%
Genotech
Market Cap: ₩7.8b
Provides products and services for gene synthesis, genome analysis, and biopharmaceuticals in South Korea and internationally.
A066830
₩1,397.00
7D
-0.07%
1Y
-8.7%
Cronex.Co.Ltd
Market Cap: ₩1.1b
Engages in the research and development of medicines and raw materials for medical research.
A215570
₩330.00
7D
-17.9%
1Y
-79.4%
Daehan New Pharm
Market Cap: ₩98.9b
Manufactures and sells pharmaceuticals and veterinary products in South Korea and internationally.
A054670
₩7,050.00
7D
-0.6%
1Y
-13.5%
IMGTLtd
Market Cap: ₩52.9b
Engages in researching and developing of an ultrasound-guided therapy technology for genetic therapy and drug delivery systems.
A456570
₩11,100.00
7D
2.7%
1Y
-34.8%
Onconic Therapeutics
Market Cap: ₩141.0b
Engages in the research and development of anti-cancer therapy in South Korea.
A476060
₩13,050.00
7D
-8.7%
1Y
n/a
Novomics
Market Cap: ₩5.4b
Designs and develops genetic molecular diagnostics solutions.
A283100
₩697.00
7D
-0.4%
1Y
-71.6%
SL Therapeutics
Market Cap: ₩3.4b
Engages in cell therapy and medical device businesses.
A258540
₩646.00
7D
-5.6%
1Y
-15.8%
HK inno.N
Market Cap: ₩1.0t
Engages in the pharmaceutical business in South Korea.
A195940
₩36,850.00
7D
-2.0%
1Y
3.1%
HLB PANAGENE
Market Cap: ₩116.6b
Develops products in the field of molecular diagnostics in South Korea.
A046210
₩2,670.00
7D
-8.1%
1Y
-43.0%
Hyundai Pharmaceutical
Market Cap: ₩90.5b
Manufactures and distributes pharmaceutical products, health food drinks, and medical devices in South Korea and internationally.
A004310
₩3,270.00
7D
-3.3%
1Y
-13.8%
RP Bio
Market Cap: ₩45.5b
A bio-health company, engages in the research, development, manufacture, and sale of soft capsules in Korea and internationally.
A314140
₩5,250.00
7D
1.5%
1Y
-44.1%
SLS BIO
Market Cap: ₩22.2b
Develops diagnostic technologies in South Korea.
A246250
₩1,624.00
7D
-3.0%
1Y
-37.3%
Korea United Pharm
Market Cap: ₩283.2b
Engages in the manufacture and sale of pharmaceutical products in South Korea.
A033270
₩19,250.00
7D
-3.0%
1Y
-18.6%
Dong Sung Bio Pharm.Co.Ltd
Market Cap: ₩87.2b
Manufactures and sells pharmaceuticals and cosmetics in South Korea.
A002210
₩3,815.00
7D
-0.8%
1Y
-26.6%
DK Life Science
Market Cap: ₩163.4b
A pharmaceutical company, develops and sells diagnostic medicines and medical devices in South Korea, the European Union, Japan, and internationally.
A303810
₩10,220.00
7D
-4.3%
1Y
n/a
3billion
Market Cap: ₩173.6b
Develops technology for rare disease drug discovery using bioinformatics and machine learning technology.
A394800
₩5,480.00
7D
-9.6%
1Y
n/a
Moogene Medi
Market Cap: ₩22.9b
Develops gene therapies based on its proprietary gene-editing platform technology.
A322970
₩2,285.00
7D
6.5%
1Y
-8.6%
ORIENT BIO
Market Cap: ₩162.3b
Operates in the bio-industry in South Korea.
A002630
₩1,369.00
7D
-19.5%
1Y
142.3%
GI Innovation
Market Cap: ₩688.9b
A bio-venture company, engages in the research and development of protein new drugs.
A358570
₩15,550.00
7D
-6.5%
1Y
18.7%
Y-Biologics
Market Cap: ₩106.9b
An antibody new drug development platform company, engages in the research and development of immuno-oncology drugs and antibody drugs.
A338840
₩7,240.00
7D
-14.3%
1Y
-41.4%
HLB SCIENCE
Market Cap: ₩33.3b
Develops biological drugs with MoA to infectious diseases.
A343090
₩2,030.00
7D
-6.5%
1Y
-19.3%
Pharmicell
Market Cap: ₩735.0b
A biopharmaceutical company, develops and sells stem cell drugs in South Korea and internationally.
A005690
₩12,250.00
7D
14.5%
1Y
95.7%
HLB Pharmaceutical
Market Cap: ₩379.1b
A pharmaceutical company, researches and develops peptide drugs in South Korea.
A047920
₩27,000.00
7D
-9.8%
1Y
-4.8%
NovMetaPharma
Market Cap: ₩45.6b
Engages in the development and sale of drugs to treat metabolic diseases in South Korea.
A229500
₩5,090.00
7D
-1.7%
1Y
n/a
ENCell
Market Cap: ₩185.0b
Develops cell/gene-based biopharmaceutical products in South Korea.
A456070
₩17,180.00
7D
-10.4%
1Y
n/a
CellBion
Market Cap: ₩223.0b
Engages in the research and development of radiopharmaceutical products.
A308430
₩17,420.00
7D
5.3%
1Y
n/a
Bio SolutionLtd
Market Cap: ₩228.3b
Develops, manufactures, and sells cell therapy products worldwide.
A086820
₩28,450.00
7D
-6.1%
1Y
74.6%
Invites Biocore
Market Cap: ₩43.1b
Provides bioanalytical and central lab services in South Korea and internationally.
A216400
₩5,590.00
7D
1.8%
1Y
-38.2%
Tdspharm
Market Cap: ₩77.5b
Researches, develops, and produces pharmaceuticals and cosmetics in South Korea and internationally.
A464280
₩14,020.00
7D
4.7%
1Y
n/a
HEM Pharma
Market Cap: ₩144.8b
Operates as a microbiome healthcare company in South Korea and internationally.
A376270
₩20,800.00
7D
9.5%
1Y
n/a
Kolon TissueGene
Market Cap: ₩3.8t
Develops cell therapies to target various orthopedic diseases and degenerative disorders.
A950160
₩46,050.00
7D
13.6%
1Y
326.4%
Femtobiomed
Market Cap: ₩40.3b
Engages in the development of cargo-free intracellular delivery platform.
A327610
₩4,875.00
7D
-5.2%
1Y
-46.4%